-
Time to train, says Vic PSA
Wednesday | Dec 3 2025THE Pharmaceutical Society of Australia (PSA) is encouraging Victorian pharmacists to enrol in its Prescribing Scope of Practice Training Program, which is now accepting enrolments.
-
CSL opens cell-based vaccine facility
Wednesday | Dec 3 2025CSL Seqirus opened its new high-tech cell-based influenza vaccine and antivenom manufacturing facility in Melbourne yesterday, with Minister for Health, Disability and Ageing Mark Butler in attendance to cut the ribbon.
-
Arrotex CEO appointment
Wednesday | Dec 3 2025DBG Health has announced the appointment of Matt Zeller as Chief Executive Officer of Arrotex Pharmaceuticals, the pharmaceutical and biological business of DBG Health.
-
Leafio partners with MedReleaf Australia, Aurora Cannabis
Wednesday | Dec 3 2025MEDICINAL cannabis distributor Leafio has announced a distribution partnership with MedReleaf Australia, whose parent company is Aurora Cannabis, a Canadian-based medical cannabis company.
-
New pertussis vaccines needed
Wednesday | Dec 3 2025A DRAMATIC spike in whooping cough cases in Australia and globally following the COVID pandemic points to a need for both increasing vaccination coverage and developing improved vaccines, according to Australian and international researchers.
-
Dispensary Corner 03 Dec 25
Wednesday | Dec 3 2025YOU can tell a lot about someone from their sweat – and not just whether they’re hot or nervous.
-
-
Mag-Sup powder – a better way to absorb magnesium
Wednesday | Dec 3 2025MAG-SUP powder is a high absorption magnesium supplement for use in magnesium deficiencies. It contains magnesium aspartate which has increased bioavailability compared to other forms of magnesium. Magnesium aspartate has better oral absorption than magnesium citrate, magnesium glycinate, magnesium chloride and magnesium oxide.
-
PD for Wed 03 Dec 2025
Wednesday | Dec 3 2025PSA urges Vic pharmacists to do prescriber training, CSL opens new cell-based vaccine facility, post-COVID pertussis spike raises alarm, and more
-
GLP-1RA safety updates
Tuesday | Dec 2 2025THE Therapeutic Goods Administration (TGA) has updated product warnings for GLP-1 and dual GIP/GLP-1 receptor agonists for two separate safety issues, based on investigations by the TGA and international regulators.
PARTNER SITES
to top